Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Cross-Talks between Raf Kinase Inhibitor Protein and Programmed Cell Death Ligand 1 Expressions in Cancer: Role in Immune Evasion and Therapeutic Implications.

  • Authors : Ho M; Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine, Jonsson Comprehensive Cancer, University of California, Los Angeles, CA 90095, USA.; Bonavida B

Subjects: B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/metabolism ; Neoplasms*/Neoplasms*/Neoplasms*/immunology ; Neoplasms*/Neoplasms*/Neoplasms*/therapy

  • Source: Cells [Cells] 2024 May 17; Vol. 13 (10). Date of Electronic Publication: 2024 May 17.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Navigating the Nexus: HIV and Breast Cancer-A Critical Review.

  • Authors : Marino A; Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, ARNAS Garibaldi Hospital, University of Catania, 95123 Catania, Italy.; Pavone G

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/complications ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/epidemiology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 12; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 12.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Programmed Death Ligand 1 Regulatory Crosstalk with Ubiquitination and Deubiquitination: Implications in Cancer Immunotherapy.

  • Authors : Kim SB; Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon 21999, Republic of Korea.; Hwang S

Subjects: B7-H1 Antigen* ; Neoplasms*; Humans

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 03; Vol. 25 (5). Date of Electronic Publication: 2024 Mar 03.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Isorhamnetin Regulates Programmed Death Ligand-1 Expression by Suppressing the EGFR-STAT3 Signaling Pathway in Canine Mammary Tumors.

  • Authors : Mei C; Institute of Animal Husbandry and Veterinary Medicine, Beijing Academy of Agriculture and Forestry Sciences, No. 11 Shuguanghuayuan Middle Road, Haidian District, Beijing 100097, China.; Department of Clinical Veterinary Medicine, College of Veterinary Medicine, China Agricultural University, No. 2 Yuanmingyuan West Road, Haidian District, Beijing 100193, China.

Subjects: B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/genetics ; Quercetin*/Quercetin*/Quercetin*/analogs & derivatives ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/veterinary

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jan 04; Vol. 25 (1). Date of Electronic Publication: 2024 Jan 04.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Autophagy as a Target for Non-Immune Intrinsic Functions of Programmed Cell Death-Ligand 1 in Cancer.

  • Authors : García-Pérez BE; Departmento de Microbiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Prolongación de Carpio y Plan de Ayala S/N, Col. Santo Tomás, Alcaldía Miguel Hidalgo, Mexico City 11340, Mexico.; Pérez-Torres C

Subjects: B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/metabolism ; Neoplasms*; Humans

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 Oct 09; Vol. 24 (19). Date of Electronic Publication: 2023 Oct 09.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

BRD4 Inhibition Enhances the Antitumor Effects of Radiation Therapy in a Murine Breast Cancer Model.

  • Authors : Kim S; Department of Tumor Biology, Graduate School of Medicine, Seoul National University, Seoul 03080, Republic of Korea.; Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul 03080, Republic of Korea.

Subjects: Neoplasms* ; Nuclear Proteins* ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 Aug 22; Vol. 24 (17). Date of Electronic Publication: 2023 Aug 22.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Editorial & Opinion

Current Landscape and Future Direction of PD-1/PD-L1 Checkpoint Inhibitors in Cancer Treatment.

  • Authors : Serratì S; Laboratory of Experimental Pharmacology, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy.; Margheri F

Subjects: B7-H1 Antigen* ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy; Humans

  • Source: Biomolecules [Biomolecules] 2023 Aug 01; Vol. 13 (8). Date of Electronic Publication: 2023 Aug 01.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Regulation of PD-L1 Expression by Nuclear Receptors.

  • Authors : Kiriyama Y; Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 769-2193, Kagawa, Japan.; Institute of Neuroscience, Tokushima Bunri University, Tokushima 769-2193, Kagawa, Japan.

Subjects: B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/genetics ; B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/metabolism ; Breast Neoplasms*

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 Jun 08; Vol. 24 (12). Date of Electronic Publication: 2023 Jun 08.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells.

  • Authors : Sánchez-León ML; Laboratory Service, Department of Medical Biochemistry, Molecular Biology and Immunology, School of Medicine, Virgen Macarena University Hospital, University of Seville, 41009 Seville, Spain.; Oncology Service, Virgen Macarena University Hospital, Department of Medicine, School of Medicine, University of Seville, 41009 Seville, Spain.

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Myeloid-Derived Suppressor Cells* ; Neoplasms*/Neoplasms*/Neoplasms*/therapy

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 Mar 08; Vol. 24 (6). Date of Electronic Publication: 2023 Mar 08.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Variable Intrinsic Expression of Immunoregulatory Biomarkers in Breast Cancer Cell Lines, Mammospheres, and Co-Cultures.

  • Authors : Montoyo-Pujol YG; Research Unit, Dr. Balmis University General Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Pintor Baeza 12, 03010 Alicante, Spain.; Medical Oncology Department, Dr. Balmis University General Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Pintor Baeza 12, 03010 Alicante, Spain.

Subjects: B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/metabolism ; Biomarkers, Tumor*/Biomarkers, Tumor*/Biomarkers, Tumor*/immunology ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/immunology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 Feb 24; Vol. 24 (5). Date of Electronic Publication: 2023 Feb 24.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
  • 1-10 of  10,030 results for ""Neoplasms""